Ontology highlight
ABSTRACT:
SUBMITTER: Wiriyatanakorn S
PROVIDER: S-EPMC6641787 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature
Wiriyatanakorn Sirichai S Sungkanuparph Somnuek S
Open forum infectious diseases 20190626 7
A randomized controlled noninferiority trial was conducted in HIV-infected patients receiving tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV) with virological suppression in a resource-limited setting. Switching to TDF/FTC/rilpivirine was noninferior to continuing TDF/FTC/EFV in terms of maintaining compete viral suppression at 24 weeks and provided better lipid profiles and fewer central nervous system adverse effects. ...[more]